Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Demonstration of quality of care measurement using the Japanese liver cancer registry.
Higashi T, Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y, Sobue T; Liver Cancer Study Group of Japan. Higashi T, et al. Among authors: izumi n. Hepatol Res. 2011 Dec;41(12):1208-15. doi: 10.1111/j.1872-034X.2011.00880.x. Epub 2011 Oct 7. Hepatol Res. 2011. PMID: 21978019
A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression.
Kanazawa N, Izumi N, Tsuchiya K, Sakurai K, Hamano K, Itakura J, Asahina Y, Noguchi O, Uchihara M, Miyake S, Miyakawa N, Kawachi Y, Shiotsu H, Taki K, Himeno Y, Enomoto N, Watanabe M, Sakai T. Kanazawa N, et al. Among authors: izumi n. Hepatol Res. 2002 Sep;24(1):80. doi: 10.1016/s1386-6346(02)00014-1. Hepatol Res. 2002. PMID: 12243795
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography.
Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, Nishimura Y, Tsuchiya K, Hamano K, Itakura J, Himeno Y, Koike M, Miyake S. Asahina Y, et al. Among authors: izumi n. Hepatol Res. 2003 Nov;27(3):196-204. doi: 10.1016/s1386-6346(03)00261-4. Hepatol Res. 2003. PMID: 14585396
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
Sugauchi F, Orito E, Ohno T, Tanaka Y, Ozasa A, Kang JH, Toyoda J, Kuramitsu T, Suzuki K, Tanaka E, Akahane Y, Ichida T, Izumi N, Inoue K, Hoshino H, Iino S, Yotsuyanagi H, Kakumu S, Tomita E, Okanoue T, Nishiguchi S, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sata M, Miyakawa Y, Ueda R, Mizokami M. Sugauchi F, et al. Among authors: izumi n. Hepatol Res. 2006 Oct;36(2):107-14. doi: 10.1016/j.hepres.2006.06.001. Epub 2006 Sep 7. Hepatol Res. 2006. PMID: 16956789
Prolonged treatment with pegylated interferon alpha 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan.
Watanabe S, Enomoto N, Koike K, Izumi N, Takikawa H, Hashimoto E, Moriyasu F, Kumada H, Imawari M; PERFECT Study Group. Watanabe S, et al. Among authors: izumi n. Hepatol Res. 2010 Feb;40(2):135-44. doi: 10.1111/j.1872-034X.2009.00567.x. Epub 2009 Sep 25. Hepatol Res. 2010. PMID: 19788694
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis.
Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Ikeda H, Itakura J, Takahashi Y, Asahina Y, Higaki M, Enomoto N, Izumi N. Kurosaki M, et al. Among authors: izumi n. Hepatol Res. 2010 Apr;40(4):251-60. doi: 10.1111/j.1872-034X.2009.00607.x. Epub 2010 Jan 11. Hepatol Res. 2010. PMID: 20070391
865 results